Medicare Enrolled

Dr. Elliot Naidus, MD

Pulmonary Disease · Burlingame, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1750 EL CAMINO REAL STE 307, Burlingame, CA 94010
6506975367
In practice since 2013 (12 years)
NPI: 1760821979 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Naidus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naidus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Naidus

Dr. Elliot Naidus is a pulmonary disease specialist in Burlingame, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Naidus performed 825 Medicare services across 589 unique beneficiaries.

Between the years covered by Open Payments, Dr. Naidus received a total of $3,449 from 15 pharmaceutical and/or device companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Naidus is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 42% volume in CA $3,449 industry payments

Medicare Practice Summary

Medicare Utilization ↗
825
Medicare services
Top 42% in CA for pulmonary disease
589
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~69 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
243 $186 $650
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
138 $114 $316
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
103 $107 $265
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
59 $165 $429
New patient office visit, complex (60-74 min) 33 $206 $516
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
30 $11 $50
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
30 $8 $50
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
27 $28 $100
Ultrasound guidance for blood vessel access
Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood.
21 $12 $100
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
21 $9 $65
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
21 $153 $525
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
21 $72 $175
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $87 $226
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
16 $18 $75
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
16 $21 $50
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $158 $392
Arterial line insertion
A tube is inserted into an artery through the skin to allow for blood sampling or infusion.
12 $38 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,449
Total received (2019-2024)
Avg $575/year across 6 years
Top 33% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
32
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,500 (72.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$949 (27.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,874
2023
$91
2022
$139
2021
$130
2020
$111
2019
$105

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$2,500
Inari Medical, Inc.
$177
GlaxoSmithKline, LLC.
$60
AstraZeneca Pharmaceuticals LP
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
United Therapeutics Corporation
$29
ERBE USA INC
$21
Merck Sharp & Dohme LLC
$19
Top 3 companies account for 95.2% of 2024 payments
All-time payments by company (2019-2024) ›
INTUITIVE SURGICAL, INC.
$2,500
GlaxoSmithKline, LLC.
$328
Inari Medical, Inc.
$177
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
AstraZeneca Pharmaceuticals LP
$58
Intuitive Surgical, Inc.
$49
Pulmonx Corporation
$44
Merck Sharp & Dohme LLC
$44
Insmed, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$30
United Therapeutics Corporation
$29
MAYNE PHARMA INC.
$23
Teva Pharmaceuticals USA, Inc.
$22
Resmed Corp
$22
ERBE USA INC
$21
Top 3 companies account for 87.1% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · Arikayce · Astral · CINQAIR · Cryo2 · DORYX · Da Vinci Surgical System · FLOWTRIEVER CATHETER · HYQVIA · OFEV · PNEUMOVAX 23 · Pulmonx Endobronchial Valve EBV · S · TRELEGY ELLIPTA · TYVASO · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware.

Looking for a pulmonary disease specialist in Burlingame?
Compare pulmonary diseases in the Burlingame area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
110
Per 100K population
14.8
County median income
$156,000
Nearest hospital
PENINSULA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Naidus is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Naidus experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Naidus performed 243 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Naidus receive payments from pharmaceutical companies?
Yes. Dr. Naidus received a total of $3,449 from 15 companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naidus's costs compare to other pulmonary diseases in Burlingame?
Dr. Naidus's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naidus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →